Granza Bio

About Granza Bio

Granza Bio is a company focused on advancing therapeutic delivery through its innovative 'precision shell' technology, inspired by the human immune system. It utilizes the discovery of 'attack particles' from the immune system's arsenal to transform the fight against diseases such as cancer, autoimmunity, and infections.

Products & Services

Precision Shell Platform:A delivery platform inspired by the immune system, designed to synthetically recreate attack particles for independent operation. It can deliver various cargo types (e.g., attack particles, RNAs, proteins, genetic modifiers), overcome immunological activation, and target a range of tissue sites and hard-to-reach organs.

Specialties

Therapeutic Cargo Delivery Precision Shell Technology Immune System-Inspired Solutions Attack Particles Research

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 7140000 MR: - FA: 7.14M FAN: 7140000	D: 2024-07-10 FD: 2024-07-10	19 investors

Seed Latest

2024-07-10

$7.1M

19 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Prof. Dustin

Professor

Recent News

Granza Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised